Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Hamilton

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Ecotoxicology (London, England)|August 18, 2011
Mercury, selenium and neurochemical biomarkers in different brain regions of migrating common loons from Lake Erie, CanadaMelanie Hamilton, Anton Scheuhammer, Niladri Basu
Journal of General Internal Medicine|April 21, 2026
Lifelines at Risk: Safety-net Hospital Closures in the U.SCamiella-Louisa Sehidou, Melanie Hamilton, Chavon Onumah
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 16, 2015
The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and CaregiversAndrew C Grant, Richard Walker, Melanie Hamilton, et al.
Frontiers in Pediatrics|March 11, 2024
Cased-based education rounds-the eternal heart of an international training programColm R Breatnach, Alejandro Floh, Melanie Hamilton, et al.
British Dental Journal|August 23, 2025
A scholarship of teaching and learning approach for the oral pathology dental curriculumMelanie Hamilton, Luke Wandzura, Walter L Siqueira, et al.
British Journal of Clinical Pharmacology|October 25, 2013
Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjectsAnn Allen, Joanne Bal, Anne Cheesbrough, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterolRodger Kempsford, Ann Allen, Philippe Bareille, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 16, 2015
In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)Melanie Hamilton, Richard Leggett, Cheng Pang, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 25, 2023
<i>In Vitro</i> Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder InhalerMelanie Hamilton, Martin Anderson, Rajiv Dhand, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trialAmanda Oliver, Ann Allen, Sandi VanBuren, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Ecotoxicology (London, England)|August 18, 2011
Mercury, selenium and neurochemical biomarkers in different brain regions of migrating common loons from Lake Erie, CanadaMelanie Hamilton, Anton Scheuhammer, Niladri Basu
Journal of General Internal Medicine|April 21, 2026
Lifelines at Risk: Safety-net Hospital Closures in the U.SCamiella-Louisa Sehidou, Melanie Hamilton, Chavon Onumah
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 16, 2015
The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and CaregiversAndrew C Grant, Richard Walker, Melanie Hamilton, et al.
Frontiers in Pediatrics|March 11, 2024
Cased-based education rounds-the eternal heart of an international training programColm R Breatnach, Alejandro Floh, Melanie Hamilton, et al.
British Dental Journal|August 23, 2025
A scholarship of teaching and learning approach for the oral pathology dental curriculumMelanie Hamilton, Luke Wandzura, Walter L Siqueira, et al.
British Journal of Clinical Pharmacology|October 25, 2013
Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjectsAnn Allen, Joanne Bal, Anne Cheesbrough, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterolRodger Kempsford, Ann Allen, Philippe Bareille, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 16, 2015
In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)Melanie Hamilton, Richard Leggett, Cheng Pang, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 25, 2023
<i>In Vitro</i> Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder InhalerMelanie Hamilton, Martin Anderson, Rajiv Dhand, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trialAmanda Oliver, Ann Allen, Sandi VanBuren, et al.
Pageof 3